Companion Animal Ear Infection Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Global Companion Animal Ear Infection Treatment Market is segmented by Product Type (Antibacterial (Aminoglycosides, Fluoroquinolones, Corticosteroids and Other Antibacterial Types)Antifungal, Corticosteroids and Other Product Types), Disease Type (Otitis Externa, Otitis Media, Otitis Interna), Animal Type (Dogs, Cats and Other Animal Types), Mode of Administration (Topical, Oral and Otic), and Geography (North America, Europe, Asia-Pacific and Rest of World). The report offers the value (in USD million) for the above segments.

Market Snapshot

companion animal ear infection treatment market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: >6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The companion animal ear infection treatment market is expected to register a CAGR of more than 6% during the forecast period, 2022-2027.

The COVID-19 pandemic is an unprecedented health concern and has significantly impacted the companion animal ear infection treatment market. The Health for Animals, Global Animal Health Association’s survey titled ‘Survey of Pet Owners Shows Impacts of COVID-19 Pandemic on Veterinary Care’ published in October 2020 reported that globally, nearly about 27% of pet owners have delayed or avoided contacting their veterinary practice since the start of the COVID-19 pandemic. Additionally, it reported that more than 1 in 10 pets missed essential, routine treatments like vaccines and flea, tick, or worm treatments due to the pandemic. Such disruption in the treatment of animal health had a short-term negative impact on the market. However, with the pandemic still in its growth phase, a surge in pet adoption was observed that indicates a positive impact on the market. For instance, according to the People's Dispensary for Sick Animals (PDSA) PAW report published in June 2021, 2 million people in the United Kingdom acquired pets between March 2020 to May 2021. This has positively impacted the market growth during the COVID-19 pandemic.

The market's growth can be attributed to the factors such as the increasing prevalence of ear infections in companion animals and growing pet and animal healthcare services.

The increasing prevalence of ear infections in companion animals drives the demand for ear infection treatment. For instance, as per a September 2021 update by the Royal Veterinary College, United Kingdom, the research shows that dogs aged over one year are at higher risk of ear infection than those under one. In addition, as per a January 2020 published article titled, "The otic microbiota and mycobiota in a referral population of dogs in the eastern USA with otitis externa," canine otitis externa (OE) is a common inflammatory disease that is frequently complicated by secondary bacterial and yeast infections and out of 40 client-owned dogs, 30 had otitis externa. Also, according to the European Pet Food Industry: Facts and Figures 2020 (FEDIAF) estimates, there were around 107,00,000 in Germany. Also, according to People's Dispensary for Sick Animals, 2021 findings revealed that 51% of the United Kingdom (UK) adults own a pet, and 26% of UK adults have a dog, with an estimated population of 9.6 million pet dogs. Thus, the statistics indicate that the burden of ear infections in dogs can increase with the growing pet population, thereby increasing the demand for ear infection treatment products. Such studies indicate the growing burden of ear infections in companion animals, thereby boosting the demand for ear infection treatment.

However, the lack of pet care and the side effects of ear infection treatment in companion animals hinder the market growth.

Scope of the Report

As per the scope of the report, an ear infection is an inflammation of the inner, middle, or outer ear with an infection and its treatment in companion animals involves various medications. The market is segmented by Product Type (Antibacterial (Aminoglycosides, Fluoroquinolones, Corticosteroids, and Other Antibacterial Types), Antifungal, Corticosteroids, and Other Product Types), Disease Type (Otitis Externa, Otitis Media, Otitis Interna), Animal Type (Dogs, Cats and Other Animal Types), Mode of Administration (Topical, Oral and Otic), and Geography (North America, Europe, Asia-Pacific and Rest of World). The report offers the value (USD million) for the above segments.

By Product Type
Antibacterial
Aminoglycosides
Fluoroquinolones
Other Antibacterial Products
Antifungal
Corticosteroids
Other Product Types
By Disease Type
Otitis Externa
Otitis Media
Otitis Interna
By Animal Type
Dogs
Cats
Other Animal Types
By Mode of Administration
Topical
Oral
Otic
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Dogs Segment is Expected to Hold a Significant Market Share in the Companion Animal Ear Infection Treatment Market

The dog's segment is expected to hold a significant market share by animal type. The major factors fueling the segment's growth are the increasing adoption of cats worldwide and the growing prevalence of ear infections in dogs.

As per a September 2021 update by the Royal Veterinary College, United Kingdom, one in every 14 dogs in the United Kingdom suffers from ear infections every year, indicating that out of 22,333 dogs, 1,631 dogs (7.3%) had an ear infection. The source also reports that sixteen breeds have an increased risk of ear infection compared with crossbred dogs.

In addition, several market players are engaged in implementing strategic initiatives, thereby contributing to market growth. For instance, in January 2020, Elanco Animal Health Incorporated signed an agreement to divest Osurnia, a treatment for otitis externa in dogs, to Dechra Pharmaceuticals PLC for USD 135 million in an all-cash deal. Moreover, in April 2020, Virbac Corporation reported the availability of EASOTIC (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Otic Suspension for Dogs, a prescription treatment for canine otitis externa.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

companion animal ear infection treatment market share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The United States is expected to retain its significant market share within North America, owing to rising pet adoption and the increasing per capita animal healthcare expenditure. Additionally, the rise in the prevalence of various animal diseases and injuries has been identified as the major factor fueling the market growth.

According to the 2021-2022 National Pet Owners Survey, conducted by the American Pet Products Association (APPA), around 70% of United States households own a pet, which equates to 90.5 million homes, including 45.3 million cats and 69 million dogs. The same source also reports that the annual expenditure on a routine visit for dogs accounts for USD 242, whereas it is 178 for cats in the country.

Moreover, the 2022 North American Pet Health Insurance Association, Inc. results for 2020 show a growth of 16.6% in total insured pets in Canada, an improvement from 2019. Thus, the demand for ear infection treatment products is anticipated to be significant in the country.

Furthermore, in March 2019, Bayer in Canada launched Claro, the only single-dose, veterinarian-administered first-line treatment for canine otitis externa. Such launches are boosting the growth of the market.

Thus, the factors above mentioabovementioned factors are expected to witness significant growth over the forecast period.

companion animal ear infection treatment market report

Competitive Landscape

The companion animals ear infection treatment market is competitive, and a few companies are currently dominating the market. The key players have been engaged in various strategic alliances, acquisitions, mergers, and launches of advanced products to secure their position in the global market. These companies include Zoetis Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Merck & Co., Inc., and Virbac Corporation.

Recent Development

In June 2021, Pet King Brands, Inc., the manufacturer of veterinarian-recommended ZYMOX Enzymatic Ear products for dogs and cats, earned the 2021 Vanguard Award for Ear Care by Pet Insight Magazine. ZYMOX Otic enzyme-based products include Ear Solutions used to manage painful ear infections and a gentle Ear Cleanser to cleanse the ears and promote ear health.

In February 2020, Bayer Animal Health launched Neptra in the United Kingdom. Neptra ear solution for dogs is the latest innovation from Bayer Animal Health, providing anti-inflammatory, anti-fungal, and anti-bacterial activity.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Ear Infection in Companion Animals

      2. 4.2.2 Growing Pet and Animal Healthcare Services

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Pet Care and Side Effects of Medications

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Antibacterial

        1. 5.1.1.1 Aminoglycosides

        2. 5.1.1.2 Fluoroquinolones

        3. 5.1.1.3 Other Antibacterial Products

      2. 5.1.2 Antifungal

      3. 5.1.3 Corticosteroids

      4. 5.1.4 Other Product Types

    2. 5.2 By Disease Type

      1. 5.2.1 Otitis Externa

      2. 5.2.2 Otitis Media

      3. 5.2.3 Otitis Interna

    3. 5.3 By Animal Type

      1. 5.3.1 Dogs

      2. 5.3.2 Cats

      3. 5.3.3 Other Animal Types

    4. 5.4 By Mode of Administration

      1. 5.4.1 Topical

      2. 5.4.2 Oral

      3. 5.4.3 Otic

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Rest of World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Vetoquinol

      2. 6.1.2 Zoetis Inc.

      3. 6.1.3 Elanco Animal Health Incorporated

      4. 6.1.4 Dechra Pharmaceuticals PLC

      5. 6.1.5 Merck & Co, Inc.

      6. 6.1.6 Virbac Corporation

      7. 6.1.7 Pet King Brands, Inc.

      8. 6.1.8 Nusentia

      9. 6.1.9 Tropiclean

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Companion Animal Ear Infection Treatment market is studied from 2019 - 2027.

The Global Companion Animal Ear Infection Treatment is growing at a CAGR of >6% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Zoetis Inc., Dechra Pharmaceuticals PLC, Merck & Co., Inc., Virbac Corporation, Elanco Animal Health Incorporated are the major companies operating in Global Companion Animal Ear Infection Treatment .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!